Nitrate Modulates Cognitive Impairment Via Oral Microbiota.

January 23, 2024 updated by: Hongqiang Sun, Peking University Sixth Hospital

The Effect of Nitrate on Cognitive Function in Alcohol Dependence Patients and the Potential Microbiota Mechanism.

Alcohol use is increasingly prevalent in modern society and is known to cause cognitive impairment and dysregulation of inflammatory responses. In the present study, the investigators want to perform a randomised controlled trials to test whether nitrate could change the oral microbiota and benefit the cognitive impairment in alcohol dependence patients. The investigators survey the oral bacterial communities in saliva samples of 70 alcohol dependent patients following 14 days of dietary inorganic nitrate (nitrate-rich beetroot juice, ~750 mg NO3- /d) and placebo (nitrate-depleted beetroot juice, ~1 mg NO3- /d) supplementation.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Anhui
      • Hefei, Anhui, China, 230022
        • Recruiting
        • Anhui Mental Health Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Han nationality
  2. Montreal Cognitive Assessment(MoCA) score >11
  3. Diagnosis of alcohol dependence

Exclusion Criteria:

  1. Past or current infectious disease
  2. Past or current heart, brain, liver, kidney, and other severe diseases
  3. Past or current metabolic diseases that can lead to abnormalities of the immune system, such as obesity (Body Mass Index > 30 kg/m2), diabetes, or rheumatoid arthritis
  4. Past or current neurodegenerative diseases, such as Parkinson's disease
  5. Use of steroidal and non-steroidal anti-inflammatory drugs, antibiotics, antioxidants, and immunosuppressive agents within two months of enrollment
  6. Use of probiotics and probiotics every day for the first two months before enrollment
  7. Previous or current DSM-IV diagnosis of schizophrenia, depression, anxiety disorder, bipolar disorder, mental retardation, dementia (excluding mild cognitive impairment, MCI), or substance dependence other than alcohol and nicotine
  8. Irregular eating habits that affect the oral flora (except alcohol) in the previous two months
  9. Current oral disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group N
nitrate-rich beetroot juice, ~750 mg NO3- /d
Placebo Comparator: Group P
nitrate-depleted beetroot juice, ~1 mg NO3- /d

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of Delayed Match to Sample Percent Correct (all delays) from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by DMS-PCAD (Delayed Match to Sample Percent Correct , all delays)
baseline and post-intervention(two weeks after baseline test)
Changes of Spatial Working Memory Between Errors from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by SWM-BE (The Spatial Working Memory Between Errors )
baseline and post-intervention(two weeks after baseline test)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of oral microbiota from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Saliva samples were used to test the composition of microbiota by 16S RNA sequencing.
baseline and post-intervention(two weeks after baseline test)
Changes of gut microbiota from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Feces samples were used to test the composition of microbiota by 16S RNA sequencing.
baseline and post-intervention(two weeks after baseline test)
Changes of Delayed Match to Sample Percent Correct (0 seconds delay) from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Delayed Match to Sample Percent Correct (0 seconds delay)
baseline and post-intervention(two weeks after baseline test)
Changes of Delayed Match to Sample Percent Correct (4 seconds delay) from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Delayed Match to Sample Percent Correct (4 seconds delay)
baseline and post-intervention(two weeks after baseline test)
Changes of Delayed Match to Sample Percent Correct (12 seconds delay) from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Delayed Match to Sample Percent Correct (12 seconds delay)
baseline and post-intervention(two weeks after baseline test)
Changes of Spatial Working Memory errors 4 boxes from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by The Spatial Working Memory errors 4 boxes
baseline and post-intervention(two weeks after baseline test)
Changes of Spatial Working Memory errors 6 boxes from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by The Spatial Working Memory errors 6 boxes
baseline and post-intervention(two weeks after baseline test)
Changes of Spatial Working Memory errors 8 boxes from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by The Spatial Working Memory errors 8 boxes
baseline and post-intervention(two weeks after baseline test)
Changes of Intra-Extra Dimensional Set Shift test Stages Completed from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by The Intra-Extra Dimensional Set Shift test Stages Completed
baseline and post-intervention(two weeks after baseline test)
Changes of Intra-Extra Dimensional Completed Stage Errors from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by The Intra-Extra Dimensional Completed Stage Errors
baseline and post-intervention(two weeks after baseline test)
Changes of Cambridge Gambling Task Risk Adjustment Merged: Risk adjustment from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Cambridge Gambling Task Risk Adjustment Merged: Risk adjustment
baseline and post-intervention(two weeks after baseline test)
Changes of Cambridge Gambling Decision Making Quality Total Merged from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Cambridge Gambling Decision Making Quality Total Merged
baseline and post-intervention(two weeks after baseline test)
Changes of Cambridge Gambling Delay Aversion Total from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Cambridge Gambling Delay Aversion Total
baseline and post-intervention(two weeks after baseline test)
Changes of Reaction Time Median Five-Choice Movement Time from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Reaction Time Median Five-Choice Movement Time
baseline and post-intervention(two weeks after baseline test)
Changes of Reaction Time Median Five-Choice Reaction Time from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by Reaction Time Median Five-Choice Reaction Time
baseline and post-intervention(two weeks after baseline test)
Changes of Rapid Visual Information Processing test Probability of False Alarm from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by the Rapid Visual Information Processing test Probability of False Alarm
baseline and post-intervention(two weeks after baseline test)
Changes of Rapid Visual Information Processing test A prime from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by the Rapid Visual Information Processing test A prime
baseline and post-intervention(two weeks after baseline test)
Changes of Rapid Visual Information Processing test Median Response Latency from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
Test by the Rapid Visual Information Processing test Median Response Latency
baseline and post-intervention(two weeks after baseline test)
Changes of nitrate levels in serum from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
The collected serum samples were used to test the levels of nitrate and nitrite by High Performance Liquid Chromatography \ HPLC
baseline and post-intervention(two weeks after baseline test)
Changes of nitrite levels in serum from baseline to post-intervention
Time Frame: baseline and post-intervention(two weeks after baseline test)
The collected serum samples were used to test the levels of nitrate and nitrite by High Performance Liquid Chromatography \ HPLC
baseline and post-intervention(two weeks after baseline test)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cytokine Interleukin-1b in serum
Time Frame: baseline and post-intervention(two weeks after baseline test)
The collected serum samples were used to test the levels of IL-1b by Enzyme-Linked Immunosorbent Assay
baseline and post-intervention(two weeks after baseline test)
Cytokine Interleukin-6 in serum
Time Frame: baseline and post-intervention (two weeks after baseline test)
The collected serum samples were used to test the levels of IL-6 by Enzyme-Linked Immunosorbent Assay
baseline and post-intervention (two weeks after baseline test)
Cytokine Interleukin-10 in serum
Time Frame: baseline and post-intervention (two weeks after baseline test)
The collected serum samples were used to test the levels of IL-10 by Enzyme-Linked Immunosorbent Assay
baseline and post-intervention (two weeks after baseline test)
Cytokine Tumor Necrosis Factor-a in serum
Time Frame: baseline and post-intervention(two weeks after baseline test)
The collected serum samples were used to test the levels of TNF-a by Enzyme-Linked Immunosorbent Assay
baseline and post-intervention(two weeks after baseline test)
The blood biochemical related parameters includes liver enzymes (alanine aminotransferase and aspartate aminotransferase)
Time Frame: baseline and post-intervention (two weeks after baseline test)
The collected venous blood were sent to the department of clinical laboratory and the investigators recorded the laboratory report.
baseline and post-intervention (two weeks after baseline test)
The blood biochemical related parameters blood fat (cholesterol, triglycerides, low density lipoprotein and high density lipoprotein
Time Frame: baseline and post-intervention (two weeks after baseline test)
The collected venous blood were sent to the department of clinical laboratory and the investigators recorded the laboratory report.
baseline and post-intervention (two weeks after baseline test)
Systolic and diastolic blood pressure
Time Frame: baseline and post-intervention (two weeks after baseline test)
Test by blood pressure monitor
baseline and post-intervention (two weeks after baseline test)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hongqiang Sun, Peking University Sixth Hospital
  • Study Chair: Liangjun Pang, Anhui mental health central

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2023

Primary Completion (Estimated)

August 7, 2024

Study Completion (Estimated)

August 7, 2024

Study Registration Dates

First Submitted

June 30, 2023

First Submitted That Met QC Criteria

July 26, 2023

First Posted (Actual)

July 27, 2023

Study Record Updates

Last Update Posted (Estimated)

January 24, 2024

Last Update Submitted That Met QC Criteria

January 23, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Dependence

Clinical Trials on nitrate-rich beetroot juice

3
Subscribe